drugset / Trial / NCT00596050

Ketamine Versus Etomidate for Procedural Sedation for Pediatric Orthopedic Reductions

NCT00596050

Phase 4 Completed 50 enrolled Drexel University College of Medicine
RandomizedParallel-groupQuadruple-blindTreatment

Summary

There are multiple retrospective studies detailing the use of etomidate in pediatric procedural sedation but few to no prospective clinical trials. None have compared etomidate to ketamine, currently the most commonly used sedative in the emergency department for pediatric procedural sedation. The investigators propose a randomized, controlled trial comparing etomidate versus ketamine for procedural sedation for fracture reduction for children presenting with extremity fracture requiring sedation for reduction. The investigators hypothesize that etomidate in combination with fentanyl will have similar reduction of distress and procedural recall as ketamine in combination with midazolam.

Timeline

Start
2006-08
Primary completion
2008-06
Completion
2008-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Etomidate Small molecule 0.2 mg/kg
Comparator Ketamine Small molecule 1 mg/kg
Comparator Fentanyl Other / unclassified 1 ug/kg
Comparator Lidocaine Other / unclassified 0.5 mg/kg
Comparator Midazolam Small molecule 0.05 mg/kg

Indications

No indication recorded.